Atlas FDA

SKINVIVE by Juvéderm

FDA premarket approval P110033/S097 · decided 2025-05-01

Approval details

PMA number
P110033
Supplement
S097
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
SKINVIVE by Juvéderm
Generic name
Implant, dermal, for aesthetic use
Applicant
Allergan
Date received
2025-04-02
Decision date
2025-05-01
Days to decision
29 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Irvine, CA
Statement
approval for updates to the postmarket surveillance data in the patient labeling and the Direction for Use (DFU) for SKINVIVE by Juvéderm

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
NATRELLE INSPIRA Single Use Sizers for Gel Implants (K203229)Allergan2021-06-02
TrueTear Intranasal Tear Neurostimulator (K193589)Allergan2020-08-31
Natrelle 133 Plus MICROCELL Tissue Expander (K180826)Allergan2018-12-21
Natrelle 133S Tissue Expander (K182054)Allergan2018-08-29
TrueTear Intranasal Tear Neurostimulator (DEN170086)Allergan2018-05-17
SERI SURGICAL SCAFFOLD (K123128)Allergan2013-04-25